Navigation Links
Risks Rise for Other Surgeries After Stent Implants
Date:5/5/2010

Danger is greatest in first six weeks, study finds

WEDNESDAY, May 5 (HealthDay News) -- People who've had a stent implanted to keep a coronary artery open face an increased risk for heart complications and death if they have non-cardiac surgery in subsequent weeks, a new Scottish study has found.

"We looked at the risks connected to four and six weeks after surgery," said study author Nicholas L.M. Cruden, a former cardiology lecturer at the University of Edinburgh and now a consultant for the National Health Service in Scotland. "Most of the risk was in the first six weeks. Between six weeks and one year, the risk was somewhat reduced, but still higher than expected."

The study, published online May 4 in Circulation: Cardiovascular Interventions, found that 42 percent of people undergoing non-cardiac surgery within six weeks of stent implantation were more likely to have such complications as decreased blood flow to the heart and heart attacks or to die. These outcomes were found in just 13 percent of those whose surgery was done more than six weeks after stent implantation.

The risk of heart problems after non-cardiac surgery was even greater for the 65 percent of people whose stents were inserted because of a recent heart attack, compared with those had stable but chronic heart disease when they were given stents, the study found.

There are no formal British guidelines about surgery after stent implantation, Cruden said, but in France, he said, guidelines recommend that such surgery be postponed at least for a year.

Guidelines issued by the American Heart Association and other organizations in the United States recommend delaying surgery for at least a year after a stent implant, said Dr. Charles W. Hogue Jr., associate professor of anesthesiology at Johns Hopkins University School of Medicine.

The pros and cons of using clot-preventing drugs such as Plavix after stent implants have been debated for years, Hogue said. "The guidelines set antiplatelet therapy for a year or maybe indefinitely," he said. "If you stop, you run the risk of stenosis [artery blockage]. But what happens if you have a tendency to bleed? That can cause all kinds of problems, particularly for the brain or the eye."

Use of clot-preventing medication has to be decided patient by patient, Hogue said. "You have to judge risk vs. benefit on an individual basis," he said. "This is a big public health issue because a lot of stents are being implanted."

About 1.3 million artery-opening procedures are performed annually in the United States, Hogue said.

The Scottish study is the largest done to date on the effects of surgery after stent implants, Cruden said. The study shows a 50 percent increase in the risk for bleeding in such cases but no impact on surgical mortality, he said.

More information

The American Heart Association has more on stents.



SOURCES: Nicholas L. M. Cruden, Ph.D., consultant, National Health Service, Glasgow, Scotland; Charles W. Hogue Jr., M.D., associate professor, anesthesiology, Johns Hopkins University School of Medicine, Baltimore; May 4, 2010, Circulation: Cardiovascular Interventions, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Study Finds Possible Explanation for the Link Between Infertility and Breast/Ovarian Cancer Risks
2. Smokers Own Secondhand Smoke Adds to Health Risks
3. Benefits outweigh risks associated with newborn screening for disorder
4. Fake Drugs Bought on the Web Pose Big Health Risks
5. Hissey Kientz, LLP Warns Birth Control Pill Users Of Increased Health Risks To Those Who Have Or Are Taking YAZ or YASMIN
6. Trauma patients safe from mortality risks associated with so-called weekend effect
7. Counterfeit Internet drugs pose significant risks and discourage vital health checks
8. Kids Who Beat Cancer Still Face Heart Risks
9. Haiti Faces Serious Health Risks in Quakes Wake
10. Studies Quantify Cancer Risks From CT Scans
11. Treadmill Desks Lower Health Risks Caused by Lack of Sleep
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are confused ... endometriosis. These women need a treatment plan to not only alleviate symptoms and ... help for preservation of fertility and ultimately achieving a pregnancy. The specialists at ...
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health ... of their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards ... at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Any dentist who has made ... the current process. Many of them do not even offer ... difficulties and high laboratory costs involved. And those who ARE ... at such a high cost that the majority of today,s ... Dr. Parsa Zadeh , founder of Dental Evolutions Inc. ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
Breaking Medicine Technology: